DX-104

· Shanghai Yuguan Biotech Co., Ltd.（Delonix Bioworks)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DX-104, covering 2026-04-06 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Clinical Trial to Assess the Safety and Immunogenicity of DX-104 [Phase 1]